M&T Bank’s Kyntra Bio KYNB Stock Holding History

M&T Bank’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-504	Closed	-$384K	–	1752
2015 Q4	$384K	Buy	+504	New	+$334K	﹤0.01%	1184

Other funds holding KYNB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

M&T Bank's KYNB Position: Q1 2016 in Review

M&T Bank sold out of Kyntra Bio (KYNB) in Q1 2016, closing a stake of 504 shares — an estimated $384K sold.

M&T Bank first reported a position in KYNB in Q4 2015 and held it in 1 quarter. The position peaked at $384K in Q4 2015. 134 funds tracked by Wall St. Rank hold KYNB as of Q1 2016.

M&T Bank reported no remaining Kyntra Bio position as of Q1 2016 after selling out during the quarter.
M&T Bank sold 504 Kyntra Bio shares in Q1 2016, an estimated $384K.
M&T Bank first reported a position in Kyntra Bio in Q4 2015 and held it in 1 quarter.
M&T Bank's Kyntra Bio position peaked at $384K in Q4 2015.
134 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2016.

Based on M&T Bank's 13F filing for Q1 2016, filed 11 May 2016.